83 related articles for article (PubMed ID: 16649999)
1. Brain lipid composition in postnatal iron-induced motor behavior alterations following chronic neuroleptic administration in mice.
Isaac G; Fredriksson A; Danielsson R; Eriksson P; Bergquist J
FEBS J; 2006 May; 273(10):2232-43. PubMed ID: 16649999
[TBL] [Abstract][Full Text] [Related]
2. Postnatal iron-induced motor behaviour alterations following chronic neuroleptic administration in mice.
Fredriksson A; Eriksson P; Archer T
J Neural Transm (Vienna); 2006 Feb; 113(2):137-50. PubMed ID: 16082515
[TBL] [Abstract][Full Text] [Related]
3. Effects of sub-chronic clozapine and haloperidol administration on brain lipid levels.
Barakauskas VE; Ypsilanti AR; Barr AM; Innis SM; Honer WG; Beasley CL
Prog Neuropsychopharmacol Biol Psychiatry; 2010 May; 34(4):669-73. PubMed ID: 20227455
[TBL] [Abstract][Full Text] [Related]
4. Sub-chronic antipsychotic drug treatment does not alter brain phospholipid fatty acid composition in rats.
Levant B; Crane JF; Carlson SE
Prog Neuropsychopharmacol Biol Psychiatry; 2006 Jun; 30(4):728-32. PubMed ID: 16442197
[TBL] [Abstract][Full Text] [Related]
5. Protective effect of Curcumin, the active principle of turmeric (Curcuma longa) in haloperidol-induced orofacial dyskinesia and associated behavioural, biochemical and neurochemical changes in rat brain.
Bishnoi M; Chopra K; Kulkarni SK
Pharmacol Biochem Behav; 2008 Feb; 88(4):511-22. PubMed ID: 18022680
[TBL] [Abstract][Full Text] [Related]
6. Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of clozapine, but not haloperidol.
Hashimoto K; Fujita Y; Shimizu E; Iyo M
Eur J Pharmacol; 2005 Sep; 519(1-2):114-7. PubMed ID: 16099452
[TBL] [Abstract][Full Text] [Related]
7. Effects of tryptophan and valine administration on behavioral pharmacology of haloperidol.
Ali O; Haleem DJ; Saify ZS; Kamil N; Obaid R; Ahmed SW
Pak J Pharm Sci; 2005 Apr; 18(2):23-8. PubMed ID: 16431394
[TBL] [Abstract][Full Text] [Related]
8. Neonatal iron exposure induces neurobehavioural dysfunctions in adult mice.
Fredriksson A; Schröder N; Eriksson P; Izquierdo I; Archer T
Toxicol Appl Pharmacol; 1999 Aug; 159(1):25-30. PubMed ID: 10448122
[TBL] [Abstract][Full Text] [Related]
9. Effect of chronic treatment with clozapine and haloperidol on 5-HT(2A and 2C) receptor mRNA expression in the rat brain.
Huang XF; Tan YY; Huang X; Wang Q
Neurosci Res; 2007 Nov; 59(3):314-21. PubMed ID: 17868938
[TBL] [Abstract][Full Text] [Related]
10. Protective effect of rutin, a polyphenolic flavonoid against haloperidol-induced orofacial dyskinesia and associated behavioural, biochemical and neurochemical changes.
Bishnoi M; Chopra K; Kulkarni SK
Fundam Clin Pharmacol; 2007 Oct; 21(5):521-9. PubMed ID: 17868205
[TBL] [Abstract][Full Text] [Related]
11. Novel oral drug administration in an animal model of neuroleptic therapy.
Schleimer SB; Johnston GA; Henderson JM
J Neurosci Methods; 2005 Aug; 146(2):159-64. PubMed ID: 16054505
[TBL] [Abstract][Full Text] [Related]
12. Repeated low dose of phencyclidine administration impairs spatial learning in mice: blockade by clozapine but not by haloperidol.
Beraki S; Kuzmin A; Tai F; Ogren SO
Eur Neuropsychopharmacol; 2008 Jul; 18(7):486-97. PubMed ID: 18242064
[TBL] [Abstract][Full Text] [Related]
13. Suppressive effect of clozapine but not haloperidol on the increases of neuropeptide-degrading enzymes and glial cells in MK-801-treated rat brain regions.
Arif M; Chikuma T; Ahmed MM; Yoshida S; Kato T
Neurosci Res; 2007 Feb; 57(2):248-58. PubMed ID: 17141345
[TBL] [Abstract][Full Text] [Related]
14. Neurobehavioral effects of tetrabromobisphenol A, a brominated flame retardant, in mice.
Nakajima A; Saigusa D; Tetsu N; Yamakuni T; Tomioka Y; Hishinuma T
Toxicol Lett; 2009 Aug; 189(1):78-83. PubMed ID: 19463927
[TBL] [Abstract][Full Text] [Related]
15. Functional consequences of iron overload in catecholaminergic interactions: the Youdim factor.
Archer T; Fredriksson A
Neurochem Res; 2007 Oct; 32(10):1625-39. PubMed ID: 17694434
[TBL] [Abstract][Full Text] [Related]
16. Rapid and selective identification of molecular species in phosphatidylcholine and sphingomyelin by conditional neutral loss scanning and MS3.
Houjou T; Yamatani K; Nakanishi H; Imagawa M; Shimizu T; Taguchi R
Rapid Commun Mass Spectrom; 2004; 18(24):3123-30. PubMed ID: 15565732
[TBL] [Abstract][Full Text] [Related]
17. Subchronic administration of haloperidol influences the functional deficits of postnatal iron administration in mice.
Fredriksson A; Archer T
Neurotox Res; 2006 Oct; 10(2):123-9. PubMed ID: 17062374
[TBL] [Abstract][Full Text] [Related]
18. Effects of acute and chronic administration of MK-801 on c-Fos protein expression in mice brain regions implicated in schizophrenia with or without clozapine.
Zuo DY; Cao Y; Zhang L; Wang HF; Wu YL
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Mar; 33(2):290-5. PubMed ID: 19121361
[TBL] [Abstract][Full Text] [Related]
19. A preliminary investigation into the effects of antipsychotics on sub-chronic phencyclidine-induced deficits in attentional set-shifting in female rats.
McLean SL; Beck JP; Woolley ML; Neill JC
Behav Brain Res; 2008 May; 189(1):152-8. PubMed ID: 18282619
[TBL] [Abstract][Full Text] [Related]
20. Involvement of adenosinergic receptor system in an animal model of tardive dyskinesia and associated behavioural, biochemical and neurochemical changes.
Bishnoi M; Chopra K; Kulkarni SK
Eur J Pharmacol; 2006 Dec; 552(1-3):55-66. PubMed ID: 17064683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
